Physician profile
Joseph E Thomas
NPI 1144315102
$1,964.15
in general payments reported to CMS, 2019-2025
24 companies · $90.77 in 2025
The $90.77 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $164 · 2021: $382 · 2022: $248 · 2023: $414 · 2024: $478 · 2025: $90.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951 · Education: $32.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.36 |
| Education | $32.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $311.74 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $309.37 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $209.46 | 2020-2023 | Tezspire |
| Amgen INC. | $194.81 | 2021-2023 | Tezspire |
| Abbott Laboratories | $172.20 | 2022-2024 | Cardiomems |
| Pfizer INC. | $134.77 | 2021-2024 | |
| Lexicon Pharmaceuticals, INC. | $105.32 | 2024 | |
| Baxter Healthcare | $72.22 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $56.68 | 2020-2025 | Eliquis |
| Sanofi-Aventis U.S. LLC | $55.61 | 2019-2021 | |
| Edwards Lifesciences Corporation | $41.49 | 2025 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $37.31 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.91 | 2024 | |
| Atricure, INC. | $32.79 | 2024 | |
| Esperion Therapeutics, INC. | $26.16 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $23.62 | 2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $21.20 | 2024 | Omvoh |
| Boston Scientific Corporation | $20.62 | 2023 | Watchman Access System |
| Vivaquant INC, Dba Rhythm Express | $20.00 | 2025 | Rhythm Express |
| Inspire Medical Systems, INC. | $19.15 | 2024 | Inspire |
| Philips North America LLC | $17.71 | 2020 | |
| Hologic Sales and Service, LLC | $17.13 | 2023 | Aptima |
| Medtronic Vascular, INC. | $16.95 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.